Enabling Data Integrity from Drug Discovery through Manufacturing
White Paper Sep 19, 2018

When discussing the success of a drug therapy, a common topic amongst biopharmaceutical companies is data quality and data integrity; what the challenges are and what the key elements are to ensuring that the latest discovery is patentable, does not result in re-conducting critical research or development studies, is accepted by the regulators, or does not result in a recall of a batch of product.
A common challenge expressed amongst the industry is how to implement processes that promote and ensure that regulatory guidance’s are being followed and that their data is of the highest integrity.
High data quality and integrity is critical to ensure patient safety and drug efficacy from research and development through to manufacturing.
Related White Papers
Download this case study to learn more about how Thermo Scientific Core LIMS™ and Core ELN™ software solutions are supporting efforts to develop the human microbiome into a new modality for drug development.
READ MOREDownload this whitepaper to gain a further understanding of the processes involved in drug manufacturing, including quality issues and improvements.
READ MOREDownload this whitepaper to learn more about the selection of cell models and paints for the process of cellular painting.
READ MORELike what you just read? You can find similar content on the communities below.
BiopharmaTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE